315 related articles for article (PubMed ID: 2475275)
1. Cardiac anaphylaxis. Complement activation as an amplification system.
del Balzo U; Polley MJ; Levi R
Circ Res; 1989 Sep; 65(3):847-57. PubMed ID: 2475275
[TBL] [Abstract][Full Text] [Related]
2. Activation of the third complement component (C3) and C3a generation in cardiac anaphylaxis: histamine release and associated inotropic and chronotropic effects.
del Balzo U; Polley MJ; Levi R
J Pharmacol Exp Ther; 1988 Sep; 246(3):911-6. PubMed ID: 2458450
[TBL] [Abstract][Full Text] [Related]
3. Effect of C3a and C5a anaphylatoxins on guinea-pig isolated blood vessels.
Marceau F; Hugli TE
J Pharmacol Exp Ther; 1984 Sep; 230(3):749-54. PubMed ID: 6332191
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary injury induced by C3a and C5a anaphylatoxins.
Stimler NP; Hugli TE; Bloor CM
Am J Pathol; 1980 Aug; 100(2):327-48. PubMed ID: 6967702
[TBL] [Abstract][Full Text] [Related]
5. Effects of human anaphylatoxins on guinea pig atria.
Huey R; Bloor CM; Hugli TE
Immunopharmacology; 1984 Dec; 8(3-4):147-54. PubMed ID: 6335143
[TBL] [Abstract][Full Text] [Related]
6. Anaphylactic actions of platelet-activating factor.
Stimler NP; Bloor CM; Hugli TE; Wykle RL; McCall CE; O'Flaherty JT
Am J Pathol; 1981 Oct; 105(1):64-9. PubMed ID: 6975043
[TBL] [Abstract][Full Text] [Related]
7. Immunopharmacology of anaphylatoxin-induced bronchoconstrictor responses.
Stimler-Gerard NP
Complement; 1986; 3(3):137-51. PubMed ID: 3026723
[TBL] [Abstract][Full Text] [Related]
8. Cardiac dysfunction caused by purified human C3a anaphylatoxin.
del Balzo UH; Levi R; Polley MJ
Proc Natl Acad Sci U S A; 1985 Feb; 82(3):886-90. PubMed ID: 2579381
[TBL] [Abstract][Full Text] [Related]
9. Generation of anaphylatoxins through proteolytic processing of C3 and C5 by house dust mite protease.
Maruo K; Akaike T; Ono T; Okamoto T; Maeda H
J Allergy Clin Immunol; 1997 Aug; 100(2):253-60. PubMed ID: 9275149
[TBL] [Abstract][Full Text] [Related]
10. Anaphylatoxin-induced release of histamine from in vitro perfused guinea pig kidney.
Abdullah NA; Assem ES; Damerau B
Agents Actions; 1988 Apr; 23(3-4):181-4. PubMed ID: 2455983
[TBL] [Abstract][Full Text] [Related]
11. Role of histamine in the spasmogenic effect of the complement peptides C3a and C5a-desArg (classical anaphylatoxin).
Sorgenfrei J; Damerau B; Vogt W
Agents Actions; 1982 Apr; 12(1-2):118-21. PubMed ID: 6177210
[TBL] [Abstract][Full Text] [Related]
12. Complement activation during systemic lupus erythematosus. C3a and C5a anaphylatoxins circulate during exacerbations of disease.
Belmont HM; Hopkins P; Edelson HS; Kaplan HB; Ludewig R; Weissmann G; Abramson S
Arthritis Rheum; 1986 Sep; 29(9):1085-9. PubMed ID: 3489467
[TBL] [Abstract][Full Text] [Related]
13. Complement activation requirements for histamine release from human leukocytes: influence of purified C3ahu and C5ahu on histamine release.
Hartman CT; Glovsky MM
Int Arch Allergy Appl Immunol; 1981; 66(3):274-81. PubMed ID: 6170591
[TBL] [Abstract][Full Text] [Related]
14. Comparative study on biological activities of various anaphylatoxins (C4a, C3a, C5a). Investigations on their ability to induce platelet secretion.
Meuer S; Hugli TE; Andreatta RH; Hadding U; Bitter-Suermann D
Inflammation; 1981 Dec; 5(4):263-73. PubMed ID: 6976935
[TBL] [Abstract][Full Text] [Related]
15. The effects of the anaphylatoxins C3a and C5a on isolated mast cells from rat and man.
Jürgensen H; Behrendt H; Damerau B; Schmutzler W
Agents Actions; 1986 Apr; 18(1-2):153-4. PubMed ID: 2425572
[TBL] [Abstract][Full Text] [Related]
16. Complement activation and anaphylatoxin (C3a and C5a) formation in preeclampsia and by amniotic fluid.
Haeger M; Bengtson A; Karlsson K; Heideman M
Obstet Gynecol; 1989 Apr; 73(4):551-6. PubMed ID: 2784554
[TBL] [Abstract][Full Text] [Related]
17. Modulation of the immune response by anaphylatoxins.
Morgan EL
Complement; 1986; 3(3):128-36. PubMed ID: 3542364
[TBL] [Abstract][Full Text] [Related]
18. Generation of human C3a, C4a, and C5a anaphylatoxins by protein A of Staphylococcus aureus and immobilized protein A reagents used in serotherapy of cancer.
Langone JJ; Das C; Bennett D; Terman DS
J Immunol; 1984 Aug; 133(2):1057-63. PubMed ID: 6610702
[TBL] [Abstract][Full Text] [Related]
19. Complement mediated inhibition of immune precipitation and solubilization generate different concentrations of complement anaphylatoxins (C4a, C3a, C5a).
Schifferli JA; Steiger G; Paccaud JP
Clin Exp Immunol; 1986 May; 64(2):407-14. PubMed ID: 3488858
[TBL] [Abstract][Full Text] [Related]
20. Cardiac dysfunction caused by recombinant human C5A anaphylatoxin: mediation by histamine, adenosine and cyclooxygenase arachidonate metabolites.
del Balzo U; Sakuma I; Levi R
J Pharmacol Exp Ther; 1990 Apr; 253(1):171-9. PubMed ID: 1691782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
